Metyrapone as Additive Treatment in Major Depression

Summary

The purpose of this study is to test whether metyrapone is an effective and safe augmenting agent in the treatment of major depression.

Timeline

Start

1998-05

Primary completion

—

Completion

2001-07

Publications

• Results Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry. 2004 Dec;61(12):1235-44. doi: 10.1001/archpsyc.61.12.1235.

Drugs

Indications